OncoCyte’s (OCX) “Equal Weight” Rating Reaffirmed at Stephens
OncoCyte (NASDAQ:OCX – Get Free Report)‘s stock had its “equal weight” rating reiterated by research analysts at Stephens in a report issued on Tuesday,Benzinga reports. They presently have a $4.00 target price on the stock. Stephens’ price target points to a potential upside of 25.79% from the company’s previous close. Several other equities research analysts […]
OncoCyte (NASDAQ:OCX – Get Free Report)‘s stock had its “equal weight” rating reiterated by research analysts at Stephens in a report issued on Tuesday,Benzinga reports. They presently have a $4.00 target price on the stock. Stephens’ price target points to a potential upside of 25.79% from the company’s previous close. Several other equities research analysts […]
